Response of People with Type 1 Diabetes for Follow Up

Sarfraz Ahmad Khan; Faiza Kamal; Rozina Arshad; Bilal Bin Younis; Rashid Ahmed

doi:10.53685/jshmdc.v1i1.38

Authors

Sarfraz Ahmad Khan DHQ Teaching Hospital, Sahiwa, Pakistan
Faiza Kamal Department of Medicine, Shalamar Medical& Dental College, Lahore, Pakistan
Rozina Arshad Department of Medicine, Shalamar Medical& Dental College, Lahore, Pakistan
Bilal Bin Younis Department of Medicine, Shalamar Medical& Dental College, Lahore, Pakistan
Rashid Ahmed Department of Medicine, Shalamar Medical& Dental College, Lahore, Pakistan

DOI:

https://doi.org/10.53685/jshmdc.v1i1.38

Abstract

Diabetes is becoming a global epidemic. Type1 diabetes (T1DM) accounts for 3-5% of all the diabetics. As T1DM
is diagnosed in childhood and adolescence, it is associated with more complications because of longer life span of
individuals with this condition. The main objective of the study was to find out attitudes of people with type 1
diabetes especially with regards to their follow up. A cross-sectional study was planned and a total of 97 people with
type 1 diabetes were included for a period of one year. To analyze the data SPSS 20.0 version was used. Results
showed that out of 97 people, 48 (49.5%) were male and 49 (50.5%) were female. The mean age of total type 1
diabetics were 17.03±6.54 years. Mean glycated hemoglobin (HbA1c) was 10.59±3.09. The results revealed that
45% of people showed positive attitude and 55% showed negative behavior towards follow-up. It was concluded
that overall follow up of people with type 1 diabetes was poor. It was observed that they wanted a complete cure and
this contribute to missed follow up.

References

Colagiuri R, Brown J, Dain K. Global diabetes plan 2011–2021. International Diabetes Federation. Brussels; 2011.

Federation ID. IDF Diabetes Atlas update poster. International Diabetes Federation. 2014.

Loghmani E. Diabetes Mellitus: Type 1 And Type 2, Chapter 14, Stang J, Story M (Eds) Guidelines for Adolescent Nutrition Services; 2005.

Gillespie KM. Type 1 diabetes: pathogenesis and prevention. Cmaj. 2006; 175(2): 165-170. DOI: https://doi.org/10.1503/cmaj.060244

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes care. 2008; 31(8): 1473-1478. DOI: https://doi.org/10.2337/dc08-0545

Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. The Lancet. 2010; 375(9733): 2254-2266. DOI: https://doi.org/10.1016/S0140-6736(10)60550-8

Imtiaz S, Ullah H, Rasool MF, Hashmat F, Saleem M, Khan N. Assessment of compliance of diabetic patients at Nishtar Hospital Multan, Pakistan. Gomal J Med Sci. 2014; 12(2): 84-8.

Khan AR, Lateef ZN, Al Aithan MA, Bu-Khamseen MA, Al Ibrahim I, Khan SA. Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. Journal of Family and Community Medicine. 2012; 19(1): 26-32. DOI: https://doi.org/10.4103/2230-8229.94008

Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. Journal of Diabetes & Metabolic Disorders. 2013; 12(1): 14. DOI: https://doi.org/10.1186/2251-6581-12-14

DCCT Research Group. Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988; 37(4): 476-481. DOI: https://doi.org/10.2337/diabetes.37.4.476

Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: a nationwide prospective study in the Netherlands. Bmj. 2004;328(7445): 915. DOI: https://doi.org/10.1136/bmj.38043.583160.EE